Logo image of AXTI

AXT INC (AXTI) Stock Fundamental Analysis

NASDAQ:AXTI - Nasdaq - US00246W1036 - Common Stock - Currency: USD

2.14  +0.06 (+2.88%)

After market: 2.15 +0.01 (+0.47%)

Fundamental Rating

2

Taking everything into account, AXTI scores 2 out of 10 in our fundamental rating. AXTI was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI may be in some trouble as it scores bad on both profitability and health. AXTI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AXTI has reported negative net income.
In the past year AXTI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
In multiple years AXTI reported negative operating cash flow during the last 5 years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -5.55%, AXTI is not doing good in the industry: 69.09% of the companies in the same industry are doing better.
AXTI has a worse Return On Equity (-10.01%) than 67.27% of its industry peers.
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROIC N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

AXTI has a worse Gross Margin (17.18%) than 83.64% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXTI has more shares outstanding
Compared to 5 years ago, AXTI has more shares outstanding
Compared to 1 year ago, AXTI has a worse debt to assets ratio.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

AXTI has an Altman-Z score of 0.51. This is a bad value and indicates that AXTI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AXTI (0.51) is worse than 73.64% of its industry peers.
AXTI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AXTI has a worse Debt to Equity ratio (0.31) than 62.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC10.38%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.99 indicates that AXTI should not have too much problems paying its short term obligations.
AXTI has a worse Current ratio (1.99) than 76.36% of its industry peers.
AXTI has a Quick Ratio of 1.99. This is a bad value and indicates that AXTI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.92, AXTI is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 0.92
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.50% over the past year.
Looking at the last year, AXTI shows a very strong growth in Revenue. The Revenue has grown by 21.42%.
The Revenue has been growing slightly by 3.59% on average over the past years.
EPS 1Y (TTM)2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)21.42%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-14.69%

3.2 Future

The Earnings Per Share is expected to grow by 35.67% on average over the next years. This is a very strong growth
AXTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.33% yearly.
EPS Next Y-108.25%
EPS Next 2Y35.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.01%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AXTI's earnings are expected to grow with 35.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXT INC

NASDAQ:AXTI (7/3/2025, 7:03:40 PM)

After market: 2.15 +0.01 (+0.47%)

2.14

+0.06 (+2.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners34.89%
Inst Owner Change-27.2%
Ins Owners2.46%
Ins Owner Change12.54%
Market Cap97.58M
Analysts83.64
Price Target3.93 (83.64%)
Short Float %1.34%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.8%
Min EPS beat(2)-130.68%
Max EPS beat(2)-42.91%
EPS beat(4)2
Avg EPS beat(4)-29.68%
Min EPS beat(4)-130.68%
Max EPS beat(4)32.39%
EPS beat(8)5
Avg EPS beat(8)-5.53%
EPS beat(12)9
Avg EPS beat(12)11.41%
EPS beat(16)12
Avg EPS beat(16)11.13%
Revenue beat(2)1
Avg Revenue beat(2)1.4%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)2.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-10.79%
Max Revenue beat(4)4.02%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)4
Avg Revenue beat(12)-1.81%
Revenue beat(16)6
Avg Revenue beat(16)-0.95%
PT rev (1m)0%
PT rev (3m)-23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-129.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-118.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS2.11
BVpS4.06
TBVpS4.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.18%
FCFM N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.97%
Cap/Sales 1.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 0.92
Altman-Z 0.51
F-Score3
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)178.33%
Cap/Depr(5y)282.49%
Cap/Sales(3y)13.27%
Cap/Sales(5y)16.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-108.25%
EPS Next 2Y35.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.42%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-14.69%
Revenue Next Year-6.01%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-85.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-378.56%
OCF growth 3YN/A
OCF growth 5YN/A